Aleta Biotherapeutics has a total of 119 patents globally, out of which 8 have been granted. Of these 119 patents, more than 63% patents are active. The United States is where Aleta Biotherapeutics has filed the maximum number of patents, followed by Japan and Mexico. Parallelly, the United States seems to be the main focused R&D center of Aleta Biotherapeutics and is also the origin country of the firm.
Aleta Biotherapeutics was founded in the year 2015 by Paul D. Rennert and Roy Lobb. The company focuses on transforming cellular therapeutics to allow a broader spectrum of cancer indications to be targeted.
Do read about some of the most popular patents of Aleta Biotherapeutics which have been covered by us in this article and also you can find Aleta Biotherapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Aleta Biotherapeutics patent portfolio.
How many patents does Aleta Biotherapeutics have?
Aleta Biotherapeutics has a total of 119 patents globally. These patents belong to 11 unique patent families. Out of 119 patents, 76 patents are active.
How Many Patents did Aleta Biotherapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Aleta Biotherapeutics Applications Filed | Aleta Biotherapeutics Patents Granted |
2022 | 3 | 2 |
2021 | 14 | 2 |
2020 | 14 | 1 |
2019 | 15 | 1 |
2018 | 36 | 2 |
2017 | 2 | – |
2016 | 32 | – |
2015 | – | – |
2014 | – | – |
2013 | – | – |
2012 | – | – |
2011 | – | – |
How many Aleta Biotherapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Aleta Biotherapeutics File in Different Countries?
Countries in which Aleta Biotherapeutics Filed Patents
Country | Patents |
United States Of America | 15 |
Japan | 10 |
Mexico | 10 |
Korea (South) | 9 |
Europe | 9 |
China | 9 |
Canada | 9 |
Israel | 9 |
Australia | 9 |
Hong Kong (S.A.R.) | 9 |
Brazil | 6 |
Chile | 4 |
Where are Research Centres of Aleta Biotherapeutics Patents Located?
10 Best Aleta Biotherapeutics Patents
CN108602872A is the most popular patent in the Aleta Biotherapeutics portfolio. It has received 15 citations so far from companies like Beijing Percans Oncology.
Below is the list of 10 most cited patents of Aleta Biotherapeutics:
Publication Number | Citation Count |
CN108602872A | 15 |
WO2017075440A1 | 13 |
WO2018156802A1 | 11 |
US20180311374A1 | 8 |
WO2017075399A1 | 6 |
KR1020180081532A | 5 |
CN108473950A | 4 |
WO2018156791A1 | 4 |
US10508143B1 | 3 |
US20200306375A1 | 3 |
What are Aleta Biotherapeutics’ key innovation segments?
What Technologies are Covered by Aleta Biotherapeutics?
The chart below distributes patents filed by Aleta Biotherapeutics